| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 2215 PILGRIM MILL CIR | CUMMING | GA | 30041 | FORSYTH | USA | Cancer Treatment Research | 000 | 3 | 6/12/2023 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 2215 PILGRIM MILL CIR | CUMMING | GA | 30041 | FORSYTH | USA | Cancer Treatment Research | 001 | 3 | 8/18/2021 | NON-COMPETING CONTINUATION | $0 |
| 2021 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 2215 PILGRIM MILL CIR | CUMMING | GA | 30041 | FORSYTH | USA | Cancer Treatment Research | 000 | 3 | 3/10/2021 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| 2020 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 12545 EL CAMINO REAL UNIT C | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | Cancer Treatment Research | 000 | 3 | 6/26/2020 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $647,711 ) |
| 2018 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 12545 EL CAMINO REAL | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | Cancer Treatment Research | 000 | 3 | 6/11/2018 | NON-COMPETING CONTINUATION | $646,311 |
| 2018 | 2018 | SIGNALRX PHARMACEUTICALS, INC. | 12545 EL CAMINO REAL | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | Cancer Treatment Research | 001 | 3 | 9/6/2018 | NON-COMPETING CONTINUATION | $1,400 |
|
| Issue Date FY: 2017 ( Subtotal = $1,320,558 ) |
| 2017 | 2017 | SIGNALRX PHARMACEUTICALS, INC. | 12545 EL CAMINO REAL | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | Cancer Treatment Research | 000 | 2 | 7/11/2017 | COMPETING CONTINUATION | $1,320,558 |
|
|